-
EP2590673
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP2590673
| EP2590673 - DESIGNER PEPTIDE-BASED PCV2 VACCINE [Right-click to bookmark this link] | Status | Grant of patent is intended Status updated on 01.02.2024 Database last updated on 18.01.2025 | |
| Former | Examination is in progress Status updated on 27.10.2017 | Most recent event Tooltip | 05.09.2024 | New entry: Additional fee for renewal fee: despatch of communication + time limit | Applicant(s) | For all designated states United Biomedical, Inc. 25 Davids Drive Hauppauge, New York 11788 / US | [2013/20] | Inventor(s) | 01 /
WANG, Chang Yi 47 Snake Hill Road Cold Spring Harbor New York 11724 / US | 02 /
PENG, Wen-Jiun 11F No. 60 Cheng-Ta Street Chung Li Taoyuan / TW | [2013/20] | Representative(s) | Weickmann & Weickmann PartmbB Postfach 860 820 81635 München / DE | [N/P] |
| Former [2013/20] | Strych, Werner Maximilian Josef Hansmann & Vogeser, Patent- und Rechtsanwälte, Albert-Rosshaupter-Strasse 65 81369 München / DE | Application number, filing date | 10854531.0 | 08.07.2010 | WO2010US41406 | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2012005732 | Date: | 12.01.2012 | Language: | EN | [2012/02] | Type: | A1 Application with search report | No.: | EP2590673 | Date: | 15.05.2013 | Language: | EN | The application published by WIPO in one of the EPO official languages on 12.01.2012 takes the place of the publication of the European patent application. | [2013/20] | Search report(s) | International search report - published on: | US | 12.01.2012 | (Supplementary) European search report - dispatched on: | EP | 25.02.2016 | Classification | IPC: | A61K39/12 | [2013/20] | CPC: |
A61K39/12 (EP,KR,US);
C07K14/01 (US);
A61K38/16 (KR);
A61K39/39 (KR);
A61P31/12 (EP);
A61P31/20 (EP);
A61P37/04 (EP);
G01N33/6878 (US);
A61K2039/552 (EP,US);
A61K2039/55566 (EP,US);
A61K2039/6031 (EP,US);
C12N2710/24111 (EP,US);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR [2013/20] | Title | German: | AUF DESIGNER-PEPTID BASIERENDER PCV2-IMPFSTOFF | [2013/20] | English: | DESIGNER PEPTIDE-BASED PCV2 VACCINE | [2013/20] | French: | VACCIN ANTI-PCV2 À BASE DE PEPTIDE ARTIFICIEL | [2013/20] | Entry into regional phase | 06.02.2013 | National basic fee paid | 06.02.2013 | Search fee paid | 06.02.2013 | Designation fee(s) paid | 06.02.2013 | Examination fee paid | Examination procedure | 06.02.2013 | Examination requested [2015/28] | 26.09.2016 | Amendment by applicant (claims and/or description) | 25.10.2017 | Despatch of a communication from the examining division (Time limit: M06) | 04.04.2018 | Reply to a communication from the examining division | 27.08.2018 | Despatch of a communication from the examining division (Time limit: M06) | 06.03.2019 | Reply to a communication from the examining division | 26.07.2019 | Despatch of a communication from the examining division (Time limit: M06) | 05.02.2020 | Reply to a communication from the examining division | 18.05.2020 | Despatch of a communication from the examining division (Time limit: M08) | 19.01.2021 | Reply to a communication from the examining division | 11.05.2021 | Despatch of a communication from the examining division (Time limit: M01) | 21.06.2021 | Reply to a communication from the examining division | 03.05.2022 | Despatch of a communication from the examining division (Time limit: M01) | 31.05.2022 | Reply to a communication from the examining division | 02.02.2024 | Communication of intention to grant the patent | 29.05.2024 | Fee for grant paid | 29.05.2024 | Fee for publishing/printing paid | 29.05.2024 | Receipt of the translation of the claim(s) | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 25.10.2017 | Fees paid | Renewal fee | 06.02.2013 | Renewal fee patent year 03 | 29.07.2013 | Renewal fee patent year 04 | 28.07.2014 | Renewal fee patent year 05 | 27.07.2015 | Renewal fee patent year 06 | 27.07.2016 | Renewal fee patent year 07 | 27.07.2017 | Renewal fee patent year 08 | 27.07.2018 | Renewal fee patent year 09 | 29.07.2019 | Renewal fee patent year 10 | 27.11.2020 | Renewal fee patent year 11 | 28.09.2021 | Renewal fee patent year 12 | 27.07.2022 | Renewal fee patent year 13 | 27.07.2023 | Renewal fee patent year 14 | Penalty fee | Additional fee for renewal fee | 31.07.2020 | 11 M06 Fee paid on 27.11.2020 | 31.07.2021 | 12 M06 Fee paid on 28.09.2021 | 31.07.2024 | 15 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [XI]WO2005092069 (VIRGINIA TECH INTELL PROP [US], et al); | [XI]WO2009000459 (UNIV GHENT [BE], et al); | [XI]WO2009085912 (WYETH CORP [US], et al) | International search | [Y]US2006029615 (REN ZHAO-JUN [US], et al); | [X]US2009017064 (WU STEPHEN QITU [US], et al); | [X]US2009162398 (WU STEPHEN QITU [US]); | [A]US2010129397 (FACHINGER VICKY [DE], et al) | Examination | WO2010068969 | by applicant | US6025468 | US6107021 | US2003165478 | US6713301 | US6906169 | US2008248061 | US2008267995 | US2009022749 | - ALLAN GM; ELLIS JA, "Porcine circoviruses: A review", J VET DIAGN INVEST, (2000), vol. 12, pages 3 - 14 | - MEEHAN BM; MCNEILLY F; TODD D; KENNEDY S; JEWHURST VA; ELLIS JA; HASSARD LE; CLARK EG; HAINES DM; ALLAN GM., "Characterization of novel circovirus DNAs associated with wasting syndromes in pigs", J GEN VIROL, (1998), vol. 79, pages 2171 - 2179 | - WALKER IW; KONOBY CA; JEWHURST VA; MCNAIR I; MCNEILLY F; MEEHAN BM; COTTRELL TS; ELLIS JA; ALLAN GM, "Development and application of a competitive enzyme-linked immunosorbent assay for the detection of serum antibodies to porcine circovirus type 2.", J VET DIAGN INVEST, (2000), vol. 12, pages 400 - 405, XP002474379 | - MCINTOSH KA; HARDING JCS; PARKER S; KRAKOWKA S; ALLAN G; ELLIS JA, "Quantitative polymerase chain reaction for Porcine circovirus-2 in swine feces in a Porcine circovirus disease-affected commercial herd and a nonaffected commercial herd.", CAN VET J, (2008), vol. 49, pages 1189 - 1194 | - MANKERTZ A; CALISKAN R; HATTERMANN K; HILLENBRAND B; KURZENDOERFER P; MUELLER B; SCHMITT C; STEINFELDT T; FINSTERBUSCH T, "Molecular biology of Porcine circovirus: Analyses of gene expression and viral replication", VET MICROBIOL, (2004), vol. 98, doi:doi:10.1016/j.vetmic.2003.10.014, pages 81 - 88, XP002423822 DOI: http://dx.doi.org/10.1016/j.vetmic.2003.10.014 | - CHEUNG AK., "Transcriptional analysis of porcine circovirus type 2", VIROLOGY, (2003), vol. 305, pages 168 - 180, XP008124766 | - NAWAGITGUL P; MOROZOV I; BOLIN SR; HARMS PA; SORDEN SD; PAUL PS., "Open reading frame 2 of porcine circovirus type 2 encodes a major capsid protein", J GEN VIROL, (2000), vol. 81, pages 2281 - 2287, XP002978778 | - LIU J; CHEN I; DU Q; CHUA H; KWANG J., "The ORF3 protein of porcine circovirus type 2 is involved in viral pathogenesis in vivo", J VIROL, (2006), vol. 80, pages 5065 - 5073 | - BLANCHARD P; MAHE D; CARIOLET R; KERANFLEC'H A; BAUDOUARD MA; CORDIOLI P; ALBINA E; JESTIN A., "Protection of swine against post-weaning multisystemic wasting syndrome (PMWS) by porcine circovirus type 2 (PCV2) proteins", VACCINE, (2003), vol. 21, doi:doi:10.1016/S0264-410X(03)00503-6, pages 4565 - 4575, XP004467337 DOI: http://dx.doi.org/10.1016/S0264-410X(03)00503-6 | - MAHE D; BLANCHARD P; TRUONG C; AMAULD C; LE CANN P; CARIOLET R; MADEC F; ALBINA E; JESTIN A., "Differential recognition of ORF2 protein from type 1 and type 2 porcine circoviruses and identification of immunorelevant epitopes", J GEN VIROL, (2000), vol. 81, pages 1815 - 1824, XP002978779 | - STEVENSON LS; GILPIN DF; DOUGLAS A; MCNEILLY F; MCNAIR I; ADAIR BM; ALLAN GM., "T lymphocyte epitope mapping of porcine circovirus type 2", VIRAL IMMUNOLOGY, (2007), vol. 20, pages 389 - 397 | - PARTIDOS CD; STANLEY CM; STEWARD MW, "Immune responses in mice following immunization with chimeric peptides representing B and T cell epitopes of measles virus protein", J GEN VIROL, (1991), vol. 72, pages 1293 - 1299, XP000996038 | - SAIZ JC; RODRIGUEZ A; GONZALEZ M; ALONSO F; SOBRINO F., "Heterotypic lymphoproliferative response in pigs vaccinated with foot-and-mouth disease virus. Involvement of isolated capsid proteins", J GEN VIROL, (1992), vol. 73, pages 2601 - 2607 | - MELOEN RH; AMERONGEN AV; HAGE-VAN NOORT M; LANGEDIJK JPM; POSTHUMUS WPA; PUYK WC; PLASMAN H; LENSTRA JA; LANGEVELD JPM., "The use of peptides to reconstruct conformational determinants; a brief review.", ANN BIOL CLIN, (1991), vol. 49, pages 231 - 242, XP000407361 | - WANG CY; WALFIELD AM, "Site-specific peptide vaccines for immunotherapy and immunization against chronic diseases, cancer, infectious diseases, and for veterinary applications", VACCINE, (2005), vol. 23, doi:doi:10.1016/j.vaccine.2005.01.007, pages 2049 - 2056, XP004777497 DOI: http://dx.doi.org/10.1016/j.vaccine.2005.01.007 | - FUERST TR; NILES EG; STUDIER FW; MOSS B, "Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase", PROC. NATL. ACAD. SCI. USA, (1986), vol. 83, doi:doi:10.1073/pnas.83.21.8122, pages 8122 - 8126, XP000563743 DOI: http://dx.doi.org/10.1073/pnas.83.21.8122 | - CHEN C-M.; LIU H-T; TU C-F, "Effects of PCV2 infection in a transgenic SPF pig farm in Taiwan", 13TH AAAP ANIM. SCI. CONGR., (20080922), page 420 | - WANG CY; SHEN M; TAM G; FANG XD; YE J; SHEN F; WALFIELD AM; WANG JJG; LI ML; LI XM, "Synthetic AIDS vaccine by targeting HIV receptor", VACCINE, (2002), vol. 21, doi:doi:10.1016/S0264-410X(02)00432-2, pages 89 - 97, XP004393289 DOI: http://dx.doi.org/10.1016/S0264-410X(02)00432-2 | - HARLOW E; LANE D, Antibodies: A Laboratory Manual., COLD SPRING HARBOR LABORATORY, (1988), pages 555 - 612 |